Answers are grounded in this paper and cite their sources.
Background: Crohn’s disease (CD) is a chronic inflammatory disease of the gastrointestinal tract with an increased risk for malignancy, particularly in patients undergoing immunosuppressive therapy. Case Presentation: This report describes the 23-year clinical course of a 20-year-old woman diagnosed with CD who, under prolonged therapy with azathioprine (AZA), developed three distinct carcinomas. The patient sequentially developed low-grade cervical intraepithelial neoplasia (CIN 1; Year 10; 3 years of AZA), a conjunctival squamous cell carcinoma (Year 14; 7 years of AZA; followed by a 10-month AZA pause), and a cutaneous basal cell carcinoma (Year 17; ~9.2 cumulative years of AZA). After CD recurrence and AZA resumption, CIN 2 was detected (Year 18; ~10.2 cumulative years of AZA). In the 18th year, AZA therapy was discontinued. Within less than one year (Year 19), cervical squamous cell carcinoma was diagnosed. In Year 23, CD was controlled, without neoplasms documented. High-risk HPV16 DNA was detected in cervical and conjunctival malignancies by PCR and confirmed by Sanger sequencing. Immunohistochemical analysis showed high Ki-67 and p16 expression and CD4+ cell predominance, supporting an association of HPV16 in these neoplasms. The short interval between CIN 2 and invasive CSCC detection is unusual. While this coincided with chronic immunosuppression, direct causality currently cannot be inferred; however, the patient’s chronic immune dysregulation and immunosuppression may be contributing factors. Conclusions: This case highlights the temporal co-occurrence of Crohn’s disease, prolonged immunosuppression, and HPV16 infection. These findings raise the need for vigilant extraintestinal cancer surveillance, regular screening, and HPV vaccination during chronic immunosuppression.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: